GABRIEL BENITEZ: Open Payments
NPI 1790251197 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 30 payments from 5 companies in 2025. Trend: 2023 $760 · 2024 $546 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $524 |
| ViiV Healthcare Company | 10 | $258 |
| Amgen Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Incyte Corporation | 1 | $17 |
Products named: APRETUDE, Yeztugo, IMDELLTRA (AMG757), KEYTRUDA, NIKTIMVO.
Industry payments across FL — which companies pay providers there.
